GUSHENGTANG (02273) announces its performance for the year 2025, with a net profit attributable to the owners of the parent company of approximately 353 million yuan, an increase of 14.99% year-on-year.

GUSHENGTANG (02273) announced its performance for the year 2025, with revenue of approximately 3.249 billion yuan, a year-on-year increase of 7.5%. Gross profit is about 1.0124 billion yuan, up 11.3% year-on-year. The profit attributable to owners of the parent company is approximately 353 million yuan, an increase of 14.99% year-on-year; basic earnings per share is 1.49 yuan. The announcement stated that the growth in revenue is mainly due to the continuous increase in revenue generated from providing medical health solutions. Revenue from providing medical health solutions increased by 7.8% to 3.22 billion yuan, mainly due to an increase in customer visits, driven by the following factors: (i) the continued increase in the number of offline medical institutions, from 79 in 2024 to 101 in 2025; and (ii) the expansion of business at existing medical institutions, with an expansion of the physician team as well.